Anip Bansal
Anschutz Medical Campus
19 Papers
14 Citations
Anip Bansal is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Medicine & Intensive care. The author has an hindex of 7, co-authored 15 publications. Previous affiliations of Anip Bansal include Columbia University & University of Colorado Denver.
Chat about Author
Papers
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
Shruti Gupta,Salim S. Hayek,Wei Wang,Lili Chan,Kusum S. Mathews,Michal L. Melamed,Samantha K. Brenner,Amanda K. Leonberg-Yoo,Edward J. Schenck,Jared Radbel,Jochen Reiser,Anip Bansal,Anand Srivastava,Yan Zhou,Anne Sutherland,Adam E. Green,Alexandre M. Shehata,Nitender Goyal,Anitha Vijayan,Juan Carlos Q. Velez,Juan Carlos Q. Velez,Shahzad Shaefi,Chirag R. Parikh,Justin Arunthamakun,Ambarish M. Athavale,Allon N. Friedman,Samuel A.P. Short,Zoe A. Kibbelaar,Samah Abu Omar,Andrew J Admon,John P. Donnelly,Hayley B. Gershengorn,Hayley B. Gershengorn,Miguel A. Hernán,Miguel A. Hernán,Matthew W. Semler,David E. Leaf +36 more
TL;DR: This study identified demographic, clinical, and hospital-level risk factors that may be associated with death in critically ill patients with COVID-19 and can facilitate the identification of medications and supportive therapies to improve outcomes.
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.
Shruti Gupta,Wei Wang,Salim S. Hayek,Lili Chan,Kusum S. Mathews,Michal L. Melamed,Samantha K. Brenner,Samantha K. Brenner,Amanda K. Leonberg-Yoo,Edward J. Schenck,Jared Radbel,Jochen Reiser,Anip Bansal,Anand Srivastava,Yan Zhou,Diana Finkel,Adam E. Green,Mary Mallappallil,Anthony J. Faugno,Jingjing Zhang,Juan Carlos Q. Velez,Juan Carlos Q. Velez,Shahzad Shaefi,Chirag R. Parikh,David M. Charytan,Ambarish M. Athavale,Allon N. Friedman,Roberta E. Redfern,Samuel A.P. Short,Simon Correa,Kapil K. Pokharel,Andrew J Admon,John P. Donnelly,Hayley B. Gershengorn,Hayley B. Gershengorn,David J. Douin,Matthew W. Semler,Miguel A. Hernán,David E. Leaf +38 more
TL;DR: Among critically ill patients with COVID-19 in this cohort study, the risk of in-hospital mortality in this study was lower in patients treated with tocilizumab in the first 2 days of ICU admission compared with patients whose treatment did not include early use of tocilzumab, and the findings may be susceptible to unmeasured confounding.
Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19.
Shahzad Shaefi,Samantha K Brenner,Shruti Gupta,Brian O’Gara,Megan L. Krajewski,David M. Charytan,Sobaata Chaudhry,Sara Mirza,Vasil Peev,Mark E. Anderson,Anip Bansal,Salim S. Hayek,Anand Srivastava,Kusum S. Mathews,Tanya S. Johns,Amanda K. Leonberg-Yoo,Adam E. Green,Justin Arunthamakun,Keith M. Wille,Tanveer Shaukat,Harkarandeep Singh,Andrew J Admon,Matthew W. Semler,Miguel A. Hernán,Miguel A. Hernán,Ariel Mueller,Wei Wang,David E. Leaf,Stop-Covid Investigators +28 more
TL;DR: In this article, the authors examined the clinical features and outcomes of 190 patients treated with ECMO within 14 days of ICU admission, using data from a multicenter cohort study of 5122 critically ill adults with COVID-19 admitted to 68 hospitals across the United States.
C3 glomerulopathy masquerading as acute postinfectious glomerulonephritis.
TL;DR: Clinical and pathologic findings were most suggestive of acute postinfectious glomerulonephritis, although the history of full nephrotic syndrome, presence of segmental membranoproliferative features, and absence of classic subepithelial hump-shaped deposits were unusual for this condition.
42
Continuous Renal Replacement Therapy Dosing in Critically Ill Patients: A Quality Improvement Initiative
Benjamin R. Griffin,Amanda Thomson,Mark Yoder,Isaiah Francis,Sophia Ambruso,Adam Bregman,Michelle Feller,Shannon Johnson-Bortolotto,Christine King,Deborah Bonnes,Lisa Dufficy,Chaorong Wu,Anip Bansal,Darlene Tad-y,Sarah Faubel,Sarah Faubel,Diana Jalal +16 more
TL;DR: An initiative to standardize CRRT practice patterns and reduce dosing variability is described, finding changes to the EMR and documentation templates and education of CRRT providers about dosing were associated with doubling of the rate of appropriate CRRT dosing and reduction in doses variability.
29